Data / Drug companies / Aluminum hydroxide and magnesium carbonate
Aluminum hydroxide and magnesium carbonate: 19 companies and 31 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Aluminum hydroxide and magnesium carbonate is listed in the FDA National Drug Code Directory by 19 companies, with 31 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, chewable; liquid; suspension, and the newest product started marketing on August 28, 2026.
The request: Get every company that lists aluminum hydroxide and magnesium carbonate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 19
- Products
- 31
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 1
- Routes
- Oral
- Brand names
- Gaviscon, Gaviscon Extra Strength, Rite Aid Extra Strength, Heartburn Relief, Extra Strength Antacid Original Flavor, Extra Strength Heartburn Relief, Acid Gone Antacid Extra Strength, Heb Extra Strength Original Flavor
- openFDA record search
- api.fda.gov
Companies that list aluminum hydroxide and magnesium carbonate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Haleon US Holdings LLC | 5 | liquid; tablet, chewable | Over the counter monograph drugs | August 1, 2014 |
| H E B | 3 | tablet, chewable; liquid | Over the counter monograph drugs | April 25, 2019 |
| CVS Pharmacy | 2 | liquid; suspension | Over the counter monograph drugs | May 15, 2019 |
| Cardinal Health 110, LLC. DBA Leader | 2 | tablet, chewable; suspension | Over the counter monograph drugs | March 4, 2019 |
| Chain Drug Marketing Association | 2 | suspension; tablet, chewable | Over the counter monograph drugs | November 1, 2019 |
| Major Pharmaceuticals | 2 | tablet, chewable; liquid | Over the counter monograph drugs | June 6, 2014 |
| Rite Aid Corporation | 2 | tablet, chewable | Over the counter monograph drugs | December 13, 2022 |
| Walgreen Company | 2 | liquid; tablet, chewable | Over the counter monograph drugs | January 15, 2018 |
| Amerisource Bergen | 1 | tablet, chewable | Over the counter monograph drugs | October 23, 2012 |
| CVS Pharmacy | 1 | tablet, chewable | Over the counter monograph drugs | August 27, 2015 |
| CVS Woonsocket Prescription Center, Incorporated | 1 | tablet, chewable | Over the counter monograph drugs | April 4, 2025 |
| Chain Drug Consortium, LLC | 1 | tablet, chewable | Over the counter monograph drugs | March 20, 2019 |
| Chain Drug Marketing Association, Inc. | 1 | tablet, chewable | Over the counter monograph drugs | July 29, 2024 |
| Geri-Care Pharmaceuticals, Corp | 1 | suspension | Over the counter monograph drugs | July 1, 2024 |
| Kroger Company | 1 | liquid | Over the counter monograph drugs | August 28, 2026 |
| Kroger Company | 1 | tablet, chewable | Over the counter monograph drugs | May 16, 2019 |
| Meijer Distribution Inc | 1 | tablet, chewable | Over the counter monograph drugs | March 16, 2017 |
| Target Corporation | 1 | tablet, chewable | Over the counter monograph drugs | August 29, 2019 |
| Wal-Mart Stores Inc | 1 | tablet, chewable | Over the counter monograph drugs | October 20, 2015 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, chewable | 19 | 61.3% |
| Liquid | 8 | 25.8% |
| Suspension | 4 | 12.9% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 31 | 100% |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.